Tudor Investment Corp
VIVO

Tudor Investment Corp’s Meridian Bioscience Inc VIVO Stock Holding History

Tudor Investment Corp’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-40,238
Closed -$821K – 2860
2021
Q4 		$821K Buy
+40,238
New +$772K 0.01% 1131
2020
Q2 		– Sell
-23,709
Closed -$199K – 1489
2020
Q1 		$199K Buy
23,709
+5,547
+31% +$46.7K 0.02% 834
2019
Q4 		$177K Sell
18,162
-75,198
-81% -$706K 0.01% 1005
2019
Q3 		$886K Sell
93,360
-14,366
-13% -$151K 0.03% 540
2019
Q2 		$1.28M Buy
107,726
+45,120
+72% +$544K 0.04% 455
2019
Q1 		$1.1M Buy
62,606
+16,713
+36% +$278K 0.05% 442
2018
Q4 		$797K Sell
45,893
-9,846
-18% -$168K 0.02% 465
2018
Q3 		$831K Buy
55,739
+7,570
+16% +$117K 0.02% 526
2018
Q2 		$766K Buy
48,169
+8,865
+23% +$132K 0.03% 530
2018
Q1 		$558K Sell
39,304
-6,738
-15% -$99.7K 0.02% 524
2017
Q4 		$645K Sell
46,042
-3,542
-7% -$51.9K 0.02% 502
2017
Q3 		$709K Buy
49,584
+17,361
+54% +$248K 0.02% 523
2017
Q2 		$508K Sell
32,223
-17,645
-35% -$254K 0.02% 567
2017
Q1 		$688K Buy
49,868
+28,353
+132% +$396K 0.02% 534
2016
Q4 		$381K Sell
21,515
-6,388
-23% -$112K 0.01% 882
2016
Q3 		$538K Sell
27,903
-13,058
-32% -$256K 0.01% 695
2016
Q2 		$799K Buy
40,961
+1,286
+3% +$25.2K 0.02% 555
2016
Q1 		$818K Buy
39,675
+21,457
+118% +$423K 0.02% 634
2015
Q4 		$374K Sell
18,218
-9,495
-34% -$182K 0.01% 1096
2015
Q3 		$474K Sell
27,713
-2,512
-8% -$45.9K 0.02% 803
2015
Q2 		$563K Buy
30,225
+1,100
+4% +$20.4K 0.02% 706
2015
Q1 		$556K Sell
29,125
-11,709
-29% -$217K 0.02% 677
2014
Q4 		$672K Buy
40,834
+16,444
+67% +$282K 0.02% 563
2014
Q3 		$431K Buy
24,390
+13,503
+124% +$265K 0.02% 766
2014
Q2 		$225K Sell
10,887
-17,203
-61% -$354K 0.01% 981
2014
Q1 		$612K Buy
28,090
+20,490
+270% +$470K 0.03% 416
2013
Q4 		$202K Sell
7,600
-5,000
-40% -$123K 0.01% 1107
2013
Q3 		$298K Buy
12,600
+2,800
+29% +$65.4K 0.01% 595
2013
Q2 		$211K Buy
+9,800
New +$211K 0.02% 710

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tudor Investment Corp's VIVO Position: Q1 2022 in Review

Tudor Investment Corp sold out of Meridian Bioscience Inc (VIVO) in Q1 2022, closing a stake of 40,238 shares — an estimated $821K sold.

Tudor Investment Corp first reported a position in VIVO in Q2 2013 and held it in 29 quarters. The position peaked at $1.28M in Q2 2019. 210 funds tracked by Wall St. Rank hold VIVO as of Q1 2022.

  • Tudor Investment Corp reported no remaining Meridian Bioscience Inc position as of Q1 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 40,238 Meridian Bioscience Inc shares in Q1 2022, an estimated $821K.
  • Tudor Investment Corp first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 29 quarters.
  • Tudor Investment Corp's Meridian Bioscience Inc position peaked at $1.28M in Q2 2019.
  • 210 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.